Related Experiment Videos
The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
M Alcalay1, L Tomassoni, E Colombo
1Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. malcalay@ieo.cilea.it
Abstract:
PML is a nuclear protein with growth-suppressive properties originally identified in the context of the PML-retinoic acid receptor alpha (RAR alpha) fusion protein of acute promyelocytic leukemia. PML localizes within distinct nuclear structures, called nuclear bodies, which are disrupted by the expression of PML-RAR alpha. We report that PML colocalizes with the nonphosphorylated fraction of the retinoblastoma protein (pRB) within nuclear bodies and that pRB is delocalized by PML-RAR alpha expression. Both PML and PML-RAR alpha form complexes with the nonphosphorylated form of pRB in vivo, and they interact with the pocket region of pRB. The regions of PML and PML-RAR alpha involved in pRB binding differ; in fact, the B boxes and the C-terminal region of PML, the latter of which is not present in PML-RAR alpha, are essential for the formation of stable complexes with pRB. Functionally, PML abolishes activation of glucocorticoid receptor-regulated transcription by pRB, whereas PML-RAR alpha further increases it. Our results suggest that PML may be part of transcription-regulatory complexes and that the oncogenic potential of the PML-RAR alpha protein may derive from the alteration of PML-regulated transcription.
Insights
The PML protein interacts with the retinoblastoma protein (pRB) in nuclear bodies. The oncogenic PML-RAR alpha fusion protein disrupts this interaction, potentially driving cancer development by altering gene transcription.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- PML (Promyelocytic Leukemia) protein is a nuclear factor with tumor-suppressive functions.
- PML localizes to nuclear bodies, structures disrupted by the PML-RAR alpha fusion protein found in acute promyelocytic leukemia.
Purpose of the Study:
- To investigate the interaction between PML and the retinoblastoma protein (pRB).
- To determine how the PML-RAR alpha fusion protein affects the PML-pRB interaction and cellular transcription.
Main Methods:
- Immunofluorescence microscopy to visualize PML and pRB localization within nuclear bodies.
- Co-immunoprecipitation assays to assess in vivo complex formation between PML, PML-RAR alpha, and pRB.
- Functional assays examining the impact on glucocorticoid receptor-regulated transcription.
Main Results:
- PML colocalizes with the nonphosphorylated fraction of pRB in nuclear bodies.
- PML-RAR alpha expression disrupts pRB localization and forms complexes with pRB via specific PML domains (B boxes, C-terminus).
- PML inhibits pRB-mediated transcriptional activation, while PML-RAR alpha enhances it.
Conclusions:
- PML is involved in transcription regulation through its interaction with pRB.
- The oncogenic activity of PML-RAR alpha may stem from its aberrant modulation of PML-regulated transcription.
- Understanding these interactions provides insights into acute promyelocytic leukemia pathogenesis.